Inicio/Acciones/QLGN

QLGN

USD

Qualigen Therapeutics Inc. Common Stock

$2.520-0.290 (-10.320%)

Precio en Tiempo Real

Healthcare

Biotecnología

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$2.810

Máximo

$2.810

Mínimo

$2.495

Volumen

0.10M

Fundamentos de la Empresa

Capitalización de Mercado

5.1M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

2.63M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $1.61Actual $2.520Máximo $8.81

Noticias Relacionadas

28 oct 2025 · 03:57

GlobeNewswire

Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025

Dubai, UAE / Beijing, China, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics Inc. (NASDAQ:QLGN) ("Qualigen", "QLGN" or the "Company"), a publicly-traded technology company majority owned by Faraday Future

Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025

13 oct 2025 · 01:00

GlobeNewswire

Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For?

Carlsbad, CA, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) (the "Company") today announced the official launch of C10 Cryptocurrency Asset Treasury (DAT) purchases: Why is this pullback